Epidemiology of Hepatitis C in Ireland, 2015. by unknown
Hepatitis C is a major cause of liver disease worldwide. The 
hepatitis C virus (HCV) is primarily transmitted through 
sharing contaminated equipment when injecting drugs or 
through receipt of unscreened blood or blood products (this 
is no longer a risk in Ireland).1,2 Sexual, occupational and 
vertical transmission can also occur but are less common.
Infection is initially asymptomatic in most cases, but 
approximately 75% of those infected fail to clear the virus and 
develop chronic infection. Between 5 and 20% of chronically 
infected individuals develop cirrhosis of the liver after 20 
years of infection. Of those with cirrhosis, 1.5% to 2.5% will 
go on to develop hepatocellular carcinoma (liver cancer) each 
year.1 There have been major advances in the treatment of 
hepatitis C in recent years. The latest generation of direct-
acting antivirals (DAAs) can cure more than 90% of patients 
using all-oral drug regimes, which have fewer side effects 
than previous treatments.3 
The overall prevalence of chronic hepatitis C in Ireland is 
comparable to other Northern European countries, and is 
estimated to be between 0.5 and 1.2%. Most cases fall into 
defined risk groups such as people who inject drugs, people 
who received unscreened blood or blood products in the past 
and people who were born in hepatitis C endemic countries.4
There were 675 notifications of hepatitis C in 2015 
(14.7/100,000 population). This is a small decrease 
compared to 2014 (n=698, 15.2/100,000 population) (figure 
1). Notifications have declined by 56% since peak levels in 
2007 (n=1,538). However recent trends indicate that levels 
are stabilizing rather than continuing to decrease. 
Notification rates for each HSE area for the past four years are 
shown in figure 2. Sixty eight percent of notifications in 2015 
were from HSE E (n=462, 28.5/100,000 population).
More than two thirds of the cases reported in 2015 were male 
(68%, n=457), 32% (n=215) were female and sex was not 
reported for three cases. The highest notification rates were in 
young to middle aged adults, with 81% (n=546) of cases aged 
between 25 and 54 years. The median age at notification has 
gradually increased from 31 years in 2004 to a high of 38.5 
years in 2015 (figures 1&3). 
Information on most likely risk factor was available for 38% 
(n=255) of the cases reported in 2015. More than three 
quarters reported injecting drug use as their most likely mode 
of infection (76%, n=194). Seven percent (n=17) were likely 
to have been infected through contaminated blood or blood 
5.2 Hepatitis C
Summary
Number of cases, 2015: 675
Crude notification rate, 2015:  14.7/100,000 population
Number of cases in 2014: 698
  
-99-HPSC Annual Epidemiological Report 2015 5 Blood-borne and Sexually Transmitted Infections
Figure 1. Number of notifications of hepatitis C and median age at notification, by sex, 2004-2015
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products, six of whom were infected in Ireland. These Irish 
infections occurred many years in the past, but were notified 
for the first time in 2015. A further 5% (n=12) reported sexual 
exposure (six heterosexual, three men who have sex with 
men and three unknown sexual orientation) and 4% (n=11) 
reported tattooing/body piercing as their most likely risk 
factor. Other risk factors were reported for nine cases and 
no risk factor was identified for twelve cases despite Public 
Health follow up. Figure 4 shows recent risk factor trends for 
hepatitis C in Ireland. 
Data on country of birth were available for 33% of cases 
(n=222) in 2015. Where information was available, 45% 
(n=99) of cases were born in Ireland, 34% (n=76) were 
Central or Eastern European, 9% (n=19) were Asian and 5% 
(n=12) were born in other Western European countries. Just 
over a third of cases with information on country of birth 
or asylum seeker status were born in a hepatitis C endemic 
country (>2% anti-HCV prevalence) or were asylum seekers. 
As data on country of birth were not very complete, this may 
not be representative of all cases. Figure 5 shows most likely 
risk factor by region of birth for the 222 cases where country 
of birth was known.
Hepatitis C genotype data were collected retrospectively 
from NVRL and were available for 50% of notifications in 
2015. Of these, 57% (n=192) were genotype 1, 36% (n=120) 
were genotype 3, 4% (n=12) were genotype 2 and 3% (n=11) 
were genotype 4. Subtype was available for 94% (n=180) of 
genotype 1 cases, 71% of which were genotype 1a. 
Co-infections can lead to more severe liver disease and 
an increased risk of liver cancer in those with hepatitis C 
infection. Nineteen of the hepatitis C cases notified in 2015 
were known to be co-infected with HIV. Where risk factor 
data were available, nine were people who inject drugs and 
two were men who have sex with men. Four additional cases 
were coinfected with hepatitis B.
Hepatitis C notifications decreased in recent years. The 
decline was fairly dramatic in 2012, but this may have 
been partially attributable to the introduction of new 
case definitions, specifically excluding cases known to 
have resolved infection. While notifications continued to 
decline slightly in 2015, hepatitis C levels now appear to be 
stabilizing rather than further declining. Trends in hepatitis 
C notifications are difficult to interpret as infections are often 
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Figure 3. Age and sex-specific notification rates/100,000 population for hepatitis C, 2015
Figure 2. Notification rates/100,000 population for hepatitis C by HSE area, 2012-2015
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initially asymptomatic and most cases that are diagnosed 
and notified are identified as a result of screening in key risk 
groups. Therefore notification trends are highly influenced 
by testing practices, which may vary over time and may not 
reflect incidence well.
Risk factor data were available for less than 40% of cases of 
hepatitis C in 2015. The distribution of risk factors for these 
cases may differ from cases where data were not available. 
Where information on risk factor was available, over three 
quarters of cases were people who inject drugs who were 
likely to have been infected through unsafe injecting 
practices. The incompleteness of our risk factor and country 
of birth data represents a significant gap in our knowledge of 
the current epidemiology of hepatitis C in Ireland. 
The figures presented in this summary are based on data 
extracted from the Computerised Infectious Disease 
Reporting (CIDR) System on 26th September 2016. These 
figures differ from those published previously due to ongoing 
updating of notification data on CIDR.
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Figure 5. Number of hepatitis C notifications by most likely risk factor and country/region of birth (where country of birth known, 33%, n=222), 2015
Figure 4. Number of hepatitis C notifications by most likely risk factor (where risk factor known, 54%, n=2956) 2010-2015
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